Patients push back against Novo Nordisk move to scrap an insulin product

Patients push back against Novo Nordisk move to scrap an insulin product

Source: 
Reuters
snippet: 
  • Patients want to keep Levemir insulin on market in US
  • Novo Nordisk: other long-acting insulins are safe alternatives
  • Company under scrutiny in Congress over high price of Wegovy